Investment for health and wellbeing
Q2 2025 report published - read moreOriola operates in the Finnish and Swedish health and wellbeing markets
Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.
Pareto Securities' Healthcare Conference
Oriola attended Pareto Securities' Healthcare Conference in Stockholm on 16 September 2025 with CEO Katarina Gabrielson as a speaker.
Oriola's science-based climate targets
Oriola’s ambitious science-based climate targets approved by the SBTi. This approval makes Oriola one of the companies globally recognised by the SBTi as having an approved science-based net-zero target under the SBTi Net-Zero Standard.
Half-Year Report 2025
Strong partnerships drive Distribution growth and profitability
Annual Report 2024
Growth through strategy implementation. Find out more about Oriola's year 2024.
Latest stock exchange releases
